FR2461500A1 - Procede de production d'une substance capable de stimuler la proliferation et la differenciation des cellules souches granulopoietiques humaines - Google Patents

Procede de production d'une substance capable de stimuler la proliferation et la differenciation des cellules souches granulopoietiques humaines Download PDF

Info

Publication number
FR2461500A1
FR2461500A1 FR8015923A FR8015923A FR2461500A1 FR 2461500 A1 FR2461500 A1 FR 2461500A1 FR 8015923 A FR8015923 A FR 8015923A FR 8015923 A FR8015923 A FR 8015923A FR 2461500 A1 FR2461500 A1 FR 2461500A1
Authority
FR
France
Prior art keywords
medium
glycoprotein
human
csf
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8015923A
Other languages
English (en)
French (fr)
Other versions
FR2461500B1 (enExample
Inventor
Fumimaro Takaku
Katsuhiro Ogasa
Morino Kuboyama
Nobuya Yanai
Muneo Yamada
Yoshiteru Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga Milk Industry Co Ltd
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP9235579A external-priority patent/JPS5618591A/ja
Priority claimed from JP6462580A external-priority patent/JPS56160994A/ja
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of FR2461500A1 publication Critical patent/FR2461500A1/fr
Application granted granted Critical
Publication of FR2461500B1 publication Critical patent/FR2461500B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR8015923A 1979-07-20 1980-07-18 Procede de production d'une substance capable de stimuler la proliferation et la differenciation des cellules souches granulopoietiques humaines Granted FR2461500A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9235579A JPS5618591A (en) 1979-07-20 1979-07-20 Production of substance capable of differentiation and multiplication of stem cells of human granulocyte
JP6462580A JPS56160994A (en) 1980-05-15 1980-05-15 Preparation of substance capable of differentiating and multiplying human granulocytic stem cell

Publications (2)

Publication Number Publication Date
FR2461500A1 true FR2461500A1 (fr) 1981-02-06
FR2461500B1 FR2461500B1 (enExample) 1984-02-17

Family

ID=26405712

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8015923A Granted FR2461500A1 (fr) 1979-07-20 1980-07-18 Procede de production d'une substance capable de stimuler la proliferation et la differenciation des cellules souches granulopoietiques humaines

Country Status (7)

Country Link
US (1) US4342828A (enExample)
CA (1) CA1128881A (enExample)
CH (1) CH644520A5 (enExample)
DE (1) DE3027105A1 (enExample)
FR (1) FR2461500A1 (enExample)
GB (1) GB2058081B (enExample)
SE (1) SE451850B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2497099A1 (fr) * 1980-12-31 1982-07-02 Hayashibara Biochem Lab Production de facteur leucopoietique humain
EP0061139A3 (en) * 1981-03-18 1983-06-01 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Mitogens of leukocytes and inflamed tissues: natural leukopoietic proteins for specific induction of proliferation and differentiation of leukocytes, process for their biotechnical preparation and pharmaceutical compositions

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432751A (en) * 1982-03-05 1984-02-21 Baylor College Of Medicine Monoclonal antibodies against lens epithelial cells and preventing proliferation of remnant lens epithelial cells after extracapsular extraction
JPS59137417A (ja) * 1983-01-28 1984-08-07 Morinaga Milk Ind Co Ltd 人尿由来コロニ−形成刺激因子及びカリクレインの製造法
JPS61227526A (ja) * 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
UA29377C2 (uk) * 1984-09-19 2000-11-15 Новартіс Аг Спосіб отримання білка з активністю колонієстимулювального фактора гранулоцитів та макрофагів(gm-csf) приматів
US5837229A (en) * 1985-02-05 1998-11-17 Chiron Corporation Uses of recombinant colony stimulating factor-1
US5573930A (en) * 1985-02-05 1996-11-12 Cetus Oncology Corporation DNA encoding various forms of colony stimulating factor-1
US5792450A (en) * 1985-02-05 1998-08-11 Chiron Corporation Purified human CSF-1
US5556620A (en) * 1985-02-05 1996-09-17 Cetus Oncology Corporation Use of recombinant colony stimulating factor-1 to enhance wound healing
AU594045B2 (en) * 1985-02-05 1990-03-01 Chiron Corporation Recombinant colony stimulating factor-1
US5104650A (en) * 1985-02-05 1992-04-14 Cetus Corporation Uses of recombinant colony stimulating factor-1
US6103224A (en) * 1985-02-05 2000-08-15 Chiron Corporation N∇2 CSF-1 (short form) and carboxy truncated fragments thereof
US6156300A (en) * 1985-02-05 2000-12-05 Chiron Corporation Point mutants of N∇2 CSF-1 and carboxy truncated fragments thereof
US5422105A (en) * 1985-02-05 1995-06-06 Cetus Oncology Corporation Use of recombinant colony stimulating factor 1
US4847201A (en) * 1985-02-05 1989-07-11 Cetus Corporation DNA encoding for CSF-1 and accompanying recombinant systems
JPH0753667B2 (ja) * 1985-08-09 1995-06-07 新技術開発事業団 骨髄移植療法補助剤
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US5160490A (en) * 1986-04-18 1992-11-03 Marrow-Tech Incorporated Three-dimensional cell and tissue culture apparatus
US4963489A (en) * 1987-04-14 1990-10-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5863531A (en) * 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5266480A (en) * 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US4721096A (en) * 1986-04-18 1988-01-26 Marrow-Tech Incorporated Process for replicating bone marrow in vitro and using the same
US5032508A (en) * 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5510254A (en) * 1986-04-18 1996-04-23 Advanced Tissue Sciences, Inc. Three dimensional cell and tissue culture system
US4871350A (en) * 1986-11-04 1989-10-03 Baylor College Of Medicine Methods and compositions for preventing secondary cataracts
US5055291A (en) * 1986-11-04 1991-10-08 Baylor College Of Medicine Compositions for preventing secondary cataracts
JPS63245667A (ja) * 1987-03-31 1988-10-12 Ube Ind Ltd 肥満細胞成長活性を有するヒトｉｌ−３産生ヒト細胞および肥満細胞成長活性を有するヒトｉｌ−３の製造方法
AU625807B2 (en) * 1987-09-22 1992-07-16 Novartis Vaccines And Diagnostics, Inc. Uses of recombinant colony stimulating factor-1
US5190876A (en) * 1988-12-27 1993-03-02 Emory University Method of modifying cellular differentiation and function and compositions therefor
BR9106354A (pt) * 1990-04-24 1993-04-27 Mark Eisenberg Equivalente de pele viva composta,seu processo de preparacao; kit de teste,seu processo de preparacao,e processo de testar efeito de substancia sobre a pele
US6211146B1 (en) 1991-03-11 2001-04-03 Curis, Inc. 60A protein-induced morphogenesis
CA2104678C (en) 1991-03-11 2002-05-14 Charles M. Cohen Protein-induced morphogenesis
US5652337A (en) * 1991-03-11 1997-07-29 Creative Biomolecules, Inc. OP-3-induced morphogenesis
US5460964A (en) * 1992-04-03 1995-10-24 Regents Of The University Of Minnesota Method for culturing hematopoietic cells
US5436151A (en) * 1992-04-03 1995-07-25 Regents Of The University Of Minnesota Method for culturing human hematopoietic stem cells in vitro
IL110195A (en) * 1994-07-03 2003-10-31 David Danon Method and system for cultivating macrophages
US6498142B1 (en) 1996-05-06 2002-12-24 Curis, Inc. Morphogen treatment for chronic renal failure
DK0980252T3 (da) 1997-05-05 2005-01-31 Curis Inc Terapier til akut nyresvigt
US8435939B2 (en) * 2000-09-05 2013-05-07 Biokine Therapeutics Ltd. Polypeptide anti-HIV agent containing the same
EP2426139B1 (en) 2002-08-27 2014-10-01 Biokine Therapeutics Ltd. CXCR4 antagonist and use thereof
US8029985B2 (en) * 2004-09-01 2011-10-04 Vybion, Inc. Amplified bioassay
EP2094274A4 (en) 2006-12-21 2011-05-11 Biokine Therapeutics Ltd T-140 PEPTIDE ANALOGUE WITH CXCR4 SUPERAGONIST ACTIVITY FOR BONE MARROW RECOVERY
WO2010092571A2 (en) 2009-02-11 2010-08-19 Yeda Research And Development Co. Ltd. Short beta-defensin-derived peptides
JP5715622B2 (ja) 2009-06-14 2015-05-07 バイオカイン セラピューティックス リミテッド 血小板レベルを増大させるためのペプチド療法
US9439942B2 (en) 2012-04-24 2016-09-13 Biokine Therapeutics Ltd. Peptides and use thereof in the treatment of large cell lung cancer
CN116196426A (zh) 2015-07-16 2023-06-02 百欧肯治疗有限公司 治疗癌症的组合物及方法
WO2017145161A1 (en) 2016-02-23 2017-08-31 Biolinerx Ltd. Methods of treating acute myeloid leukemia

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4135975A (en) * 1977-12-14 1979-01-23 Lichtman Marshall A Obtaining human cell lines that elaborate colony stimulating activity for marrow cells of man and other species and methods of preparing same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
AU523077B2 (en) * 1978-03-20 1982-07-08 Green Cross Corporation, The Hgi glycoprotein

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4135975A (en) * 1977-12-14 1979-01-23 Lichtman Marshall A Obtaining human cell lines that elaborate colony stimulating activity for marrow cells of man and other species and methods of preparing same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 89, no. 17, 23 octobre 1978, réf.: 142164t, page 213 (COLUMBUS, OHIO, US) MOTOYOSHI, KAZUO et al.: "Colony-stimulating factor. I. Purification and some properties of colony-stimulating factor from human urine", & IGAKU NO AYUMI 1978, 106(2), 72-4 *
CHEMICAL ABSTRACTS, vol. 90, no. 1, 1er janvier 1979, réf.: 1931z, page 192 (COLUMBUS, OHIO, US) MOTOYOSHI, KAZUO et al.: "Purification and some properties of colony-stimulating factor from normal human urine", & Blood 1978, 52(5), 1012-20 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2497099A1 (fr) * 1980-12-31 1982-07-02 Hayashibara Biochem Lab Production de facteur leucopoietique humain
EP0061139A3 (en) * 1981-03-18 1983-06-01 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Mitogens of leukocytes and inflamed tissues: natural leukopoietic proteins for specific induction of proliferation and differentiation of leukocytes, process for their biotechnical preparation and pharmaceutical compositions

Also Published As

Publication number Publication date
CH644520A5 (de) 1984-08-15
GB2058081A (en) 1981-04-08
DE3027105C2 (enExample) 1988-08-25
GB2058081B (en) 1983-02-09
SE8005256L (sv) 1981-01-21
SE451850B (sv) 1987-11-02
US4342828A (en) 1982-08-03
FR2461500B1 (enExample) 1984-02-17
CA1128881A (en) 1982-08-03
DE3027105A1 (de) 1981-02-12

Similar Documents

Publication Publication Date Title
FR2461500A1 (fr) Procede de production d'une substance capable de stimuler la proliferation et la differenciation des cellules souches granulopoietiques humaines
US4406830A (en) Regulatory glycoprotein for immune response and the use thereof in the production of T-cell growth factor
JPS59137417A (ja) 人尿由来コロニ−形成刺激因子及びカリクレインの製造法
US20080319163A1 (en) Method for Isolating and Purifying Immuno-Modulating Polypeptide from Cow Placenta
DE3687097T2 (de) Therapeutisches mittel zur behandlung haematopoietischer krankheiten.
TW202012433A (zh) 一種重組人胰島素或其類似物的前驅物的製備方法
JPS6041615A (ja) コロニ−形成刺激因子の製造方法
CN106754714B (zh) 脐带血样品稀释液、试剂盒及处理脐带血获得干细胞的方法
US5244807A (en) Production of pseudomonas xa cells containing indolyl-3-alkane alpha-hydroxylase
US4681844A (en) Process for producing an Interleukin-1 preparation
US4661447A (en) Regulatory glycoprotein for immune response and the use there of in the production of T-cell growth factor
RU2799637C1 (ru) Способ получения биологически активного пептидно-аминокислотного препарата на основе плазмы крови человека
NO135709B (enExample)
JPH02502640A (ja) Ｇｍ‐ｃｓｆの精製
JPH06502621A (ja) ヒトｍｅｇ―ｃｓｆタンパク質と方法
RU2286350C1 (ru) Способ получения ветеринарного альбумина
JPS6237605B2 (enExample)
US4808533A (en) Method of preventing T-cell blastogenesis
CN111019914A (zh) 一种超氧化物歧化酶的纯化方法
KR20250133318A (ko) 경비투여용 의약조성물
RU2301072C1 (ru) Средство, нормализующее функции кровеносных сосудов, и способ его получения
CN119799632A (zh) 一种功能增强的间充质干细胞外泌体的制备方法及其应用
JPH0144199B2 (enExample)
CN1307116A (zh) 一种超氧化物歧化酶的生产方法
JPH0474360B2 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse